Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Terminated 1No longer available 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Leukemia 11Myelodysplastic Syndromes 9Leukemia, Myeloid, Acute 9Lymphoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Anemia, Refractory, with Excess of Blasts 7Primary Myelofibrosis 6Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Lymphocytic, Chronic, B-Cell 6Congenital Abnormalities 6Anemia, Refractory 6Neoplasms, Plasma Cell 5Myeloproliferative Disorders 5Leukemia, Myelomonocytic, Juvenile 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Leukemia, Myeloid, Accelerated Phase 5Hodgkin Disease 5Dendritic Cell Sarcoma, Interdigitating 5Burkitt Lymphoma 5Blast Crisis 5Sezary Syndrome 4Recurrence 4

Interventions

fludarabine phosphate 6Rituximab 5Antilymphocyte Serum 5Tacrolimus 4Cyclophosphamide 4pegaspargase 3Whole-Body Irradiation 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Oxaliplatin 3Mycophenolic Acid 3Etoposide 3Dasatinib 3Vincristine 2Melphalan 2Lenalidomide 2Gemcitabine 2Filgrastim 2Doxorubicin 2Busulfan 2tislelizumab 1thymoglobulin 1tanespimycin 1plerixafor 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1obatoclax 1gemcitabine-oxaliplatin regimen 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma, Extranodal NK-T-Cell × Cord Blood Stem Cell Transplantation × Clear all
NCT00827099 2012-03-23

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Northside Hospital, Inc.

Phase 2 Terminated
5 enrolled 5 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Blast Crisis, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡